Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brody

Showing results (491-500 of 517) with videos related to

Pageof 52
Sort By:
Oncogene|September 22, 2015
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cellsF F Blanco, M Jimbo, J Wulfkuhle, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2018
Host <i>IDO2</i> Gene Status Influences Tumor Progression and Radiotherapy Response in <i>KRAS</i>-Driven Sporadic Pancreatic CancersAvinoam Nevler, Alexander J Muller, Erika Sutanto-Ward, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Cancer Biology & Therapy|July 29, 2016
Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancerJonathan R Brody, Cinthya S Yabar, Mahsa Zarei, et al.
Cancer Biology & Therapy|March 13, 2014
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trialFlorencia McAllister, Danielle M Pineda, Masaya Jimbo, et al.
Cancer Biology & Therapy|March 11, 2021
Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical modelChristopher W Schultz, Gorka Ruiz de Garibay, Anika Langer, et al.
Cancer Research|June 28, 2017
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer CellsMahsa Zarei, Shruti Lal, Seth J Parker, et al.
Genes & Development|May 15, 2026
MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stressGabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Pageof 52

Showing results (491-500 of 517) with videos related to

Sort By:
Pageof 52
Oncogene|September 22, 2015
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cellsF F Blanco, M Jimbo, J Wulfkuhle, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2018
Host <i>IDO2</i> Gene Status Influences Tumor Progression and Radiotherapy Response in <i>KRAS</i>-Driven Sporadic Pancreatic CancersAvinoam Nevler, Alexander J Muller, Erika Sutanto-Ward, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Cancer Biology & Therapy|July 29, 2016
Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancerJonathan R Brody, Cinthya S Yabar, Mahsa Zarei, et al.
Cancer Biology & Therapy|March 13, 2014
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trialFlorencia McAllister, Danielle M Pineda, Masaya Jimbo, et al.
Cancer Biology & Therapy|March 11, 2021
Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical modelChristopher W Schultz, Gorka Ruiz de Garibay, Anika Langer, et al.
Cancer Research|June 28, 2017
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer CellsMahsa Zarei, Shruti Lal, Seth J Parker, et al.
Genes & Development|May 15, 2026
MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stressGabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Pageof 52